These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 9499672

  • 1. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
    Molica S.
    Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
    [Abstract] [Full Text] [Related]

  • 2. Clinico-prognostic implications of increased levels of soluble CD54 in the serum of B-cell chronic lymphocytic leukemia patients. Results of a multivariate survival analysis.
    Molica S, Levato D, Dell' Olio M, Cascavilla N, Matera R, Minervini M, Dattilo A, Carotenuto M, Musto P.
    Haematologica; 1997; 82(2):148-51. PubMed ID: 9175316
    [Abstract] [Full Text] [Related]

  • 3. Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cells.
    Zarcone D, De Rossi G, Tenca C, Marroni P, Mauro FR, Cerruti GM, Albi N, Fiorucci S, Velardi A, Grossi CE.
    Haematologica; 1998 Dec; 83(12):1088-98. PubMed ID: 9949626
    [Abstract] [Full Text] [Related]

  • 4. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
    Molica S, Vitelli G, Levato D, Levato L, Dattilo A, Gandolfo GM.
    Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
    [Abstract] [Full Text] [Related]

  • 5. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B.
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [Abstract] [Full Text] [Related]

  • 6. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [Abstract] [Full Text] [Related]

  • 7. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
    Montillo M, Hamblin T, Hallek M, Montserrat E, Morra E.
    Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
    [Abstract] [Full Text] [Related]

  • 8. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
    Molica S, Levato D, Dell'Olio M, Matera R, Minervini M, Dattilo A, Carotenuto M, Musto P.
    Haematologica; 1996 Mar; 81(5):428-33. PubMed ID: 8952156
    [Abstract] [Full Text] [Related]

  • 9. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
    Molica S, De Rossi G, Luciani M, Levato D.
    Haematologica; 1995 Mar; 80(2):176-93. PubMed ID: 7628755
    [Abstract] [Full Text] [Related]

  • 10. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
    Schwarz J, Mikulenková D, Cermáková M, Polanská V, Michalová K, Marinov I, Campr V, Ransdorfová S, Marková J, Pavlistová L, Brezinová J, Sajdová J, Sponerová D, Volková Z, Benesová K, Cermák J, Vítek A, Cetkovský P.
    Neoplasma; 2006 Mar; 53(3):219-25. PubMed ID: 16652191
    [Abstract] [Full Text] [Related]

  • 11. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S, López A, Rasillo A, Sayagués JM, Barrena S, Sánchez ML, Teodosio C, Giraldo P, Giralt M, Pérez MC, Romero M, Perdiguer L, Orfao A.
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [Abstract] [Full Text] [Related]

  • 12. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.
    Pangalis GA, Angelopoulou MK, Vassilakopoulos TP, Siakantaris MP, Kittas C.
    Semin Hematol; 1999 Apr; 36(2):104-14. PubMed ID: 10319379
    [Abstract] [Full Text] [Related]

  • 13. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
    Eisterer W, Bechter O, Söderberg O, Nilsson K, Terol M, Greil R, Thaler J, Herold M, Finke L, Günthert U, Montserrat E, Stauder R.
    Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
    [Abstract] [Full Text] [Related]

  • 14. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
    Klobusická M, Kusenda J, Babusíková O.
    Neoplasma; 2002 Oct; 49(6):387-93. PubMed ID: 12584586
    [Abstract] [Full Text] [Related]

  • 15. CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily.
    Molica S, Vitelli G, Levato D, Crispino G, Dell'Olio M, Dattilo A, Matera R, Gandolfo GM, Musto P.
    Haematologica; 1998 May; 83(5):398-402. PubMed ID: 9658722
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E, Norberg M, Kanduri M, Tobin G, Säisänen L, Aberg M, Gustafsson MG, Sundström C, Rosenquist R, Aleskog A.
    Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
    [Abstract] [Full Text] [Related]

  • 17. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E, Domingo-Clarós A, Gonzàlez-Barca E, Beneitez D, Alonso E, Romagosa V, De Sanjos S, Petit J, Grañena A, Fernández de Sevilla A.
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [Abstract] [Full Text] [Related]

  • 18. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
    Ottaggio L, Viaggi S, Zunino A, Zupo S, Rossi E, Spriano M, Abbondandolo A, Ferrarini M.
    Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555
    [Abstract] [Full Text] [Related]

  • 19. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, Sharifian RA, Shamsian Khoramabadi A, Rabbani H, Shokri F.
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [Abstract] [Full Text] [Related]

  • 20. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M.
    Cancer; 2003 Apr 15; 97(8):1914-9. PubMed ID: 12673718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.